Termination for Failure to Develop. In respect of any particular Sub-Territory, if POINT has notified as per Section 17.9 (Notices) the Licensor that it has ceased, during at least [***] consecutive calendar months, for any reason, all Development or commercialization activities in such Sub-Territory as outlined in the Commercialization Plan. For clarity, in such situation the termination will apply only to the respective Sub-Territory(ies).
Appears in 2 contracts
Sources: Exclusive License and Commercialization Agreement (Therapeutics Acquisition Corp.), Exclusive License and Commercialization Agreement (Therapeutics Acquisition Corp.)